7:15am PDT - April 11th, 2022
Evaluate strategies to monitor and manage adverse events associated with novel therapies for relapsed/refractory #multiplemyeloma in this #CME #NCPD activity. Start now! https://t.co/8QLvdPRgnd #myeloma #bloodcancer #hematology #oncology #multiplemyelomaawareness https://t.co/otGK0wVxrW
0 retweets 0 likes - i3 Health (@i3health)